Our findings suggested that targeting Oct4/Nanog-mediated Stat3 signaling pathway may represent a novel approach to overcome EMT process in liver cancer cells displaying stem cell marker properties during tumor progression. The gene discussed is POU5F1; the disease is liver cancer.